97 related articles for article (PubMed ID: 11100346)
1. Surgery-induced decline in circulating dendritic cells in operable cancer patients: a possible explanation of postoperative immunosuppression.
Brivio F; Gilardi R; Bucocev R; Ferrante R; Rescaldani R; Vigoré L; Fumagalli L; Nespoli A; Lissoni P
Hepatogastroenterology; 2000; 47(35):1337-9. PubMed ID: 11100346
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of surgery-induced decline in circulating dendritic cells by subcutaneous preoperative administration of IL-2 in operable cancer patients.
Brivio F; Lissoni P; Gilardi R; Ferrante R; Vigore L; Curzi L; Uggeri F; Nespoli A; Fumagalli L
J Biol Regul Homeost Agents; 2000; 14(3):200-3. PubMed ID: 11037053
[TBL] [Abstract][Full Text] [Related]
3. Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease.
Lissoni P; Vigore L; Ferranti R; Bukovec R; Meregalli S; Mandala M; Barni S; Tancini G; Fumagalli L; Giani L
J Biol Regul Homeost Agents; 1999; 13(4):216-9. PubMed ID: 10703945
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of surgery-induced IL-6 hypersecretion by presurgical immunotherapy with IL-2 and its importance in the prevention of postoperative complications.
Brivio F; Lissoni P; Perego MS; Lissoni A; Fumagalli L
J Biol Regul Homeost Agents; 2001; 15(4):370-4. PubMed ID: 11860226
[TBL] [Abstract][Full Text] [Related]
5. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
Lissoni P; Malugani F; Bonfanti A; Bucovec R; Secondino S; Brivio F; Ferrari-Bravo A; Ferrante R; Vigoré L; Rovelli F; Mandalà M; Viviani S; Fumagalli L; Gardani GS
J Biol Regul Homeost Agents; 2001; 15(2):140-4. PubMed ID: 11501971
[TBL] [Abstract][Full Text] [Related]
6. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
7. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Piacentini MG; Franciosi C; Caprotti R; De Fina S; Cesana G; Uggeri F; Conti M; Uggeri F
Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847
[TBL] [Abstract][Full Text] [Related]
8. Effects of IL-2 preoperative immunotherapy on surgery-induced changes in angiogenic regulation and its prevention of VEGF increase and IL-12 decline.
Brivio F; Lissoni P; Rovelli F; Nespoli A; Uggeri F; Fumagalli L; Gardani G
Hepatogastroenterology; 2002; 49(44):385-7. PubMed ID: 11995457
[TBL] [Abstract][Full Text] [Related]
9. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers.
Romano F; Uggeri F; Crippa S; Di Stefano G; Scotti M; Scaini A; Caprotti R; Uggeri F
J Exp Clin Cancer Res; 2004 Jun; 23(2):195-200. PubMed ID: 15354402
[TBL] [Abstract][Full Text] [Related]
10. Effects of perioperative cimetidine administration on peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: results of a randomized controlled clinical trial.
Li Y; Yang GL; Yuan HY; Bai DJ; Wang K; Lin CR; Hu MB; Feng MH
Hepatogastroenterology; 2005; 52(62):504-8. PubMed ID: 15816467
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets.
Beckebaum S; Zhang X; Chen X; Yu Z; Frilling A; Dworacki G; Grosse-Wilde H; Broelsch CE; Gerken G; Cicinnati VR
Clin Cancer Res; 2004 Nov; 10(21):7260-9. PubMed ID: 15534100
[TBL] [Abstract][Full Text] [Related]
12. Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients.
Lissoni P; Brivio F; Brivio O; Fumagalli L; Gramazio F; Rossi M; Emanuelli G; Alderi G; Lavorato F
J Biol Regul Homeost Agents; 1995; 9(1):31-3. PubMed ID: 8553906
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses.
Athanassopoulos P; Vaessen LM; Maat AP; Balk AH; Weimar W; Bogers AJ
Eur J Cardiothorac Surg; 2004 Apr; 25(4):619-26. PubMed ID: 15037281
[TBL] [Abstract][Full Text] [Related]
14. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome.
Yamaguchi Y; Hihara J; Hironaka K; Ohshita A; Okita R; Okawaki M; Matsuura K; Nagamine I; Ikeda T; Ohara M; Hamai Y
Oncol Rep; 2006 Apr; 15(4):895-901. PubMed ID: 16525677
[TBL] [Abstract][Full Text] [Related]
15. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance.
Strauss L; Volland D; Kunkel M; Reichert TE
Med Sci Monit; 2005 Aug; 11(8):BR280-92. PubMed ID: 16049374
[TBL] [Abstract][Full Text] [Related]
16. T-helper/T-regulator lymphocyte ratio as a new immunobiological index to quantify the anticancer immune status in cancer patients.
Brivio F; Fumagalli L; Parolini D; Messina G; Rovelli F; Rescaldani R; Vigore L; Vezzo R; Vaghi M; Di Bella S; Lissoni P
In Vivo; 2008; 22(5):647-50. PubMed ID: 18853761
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
McCarter MD; Baumgartner J; Escobar GA; Richter D; Lewis K; Robinson W; Wilson C; Palmer BE; Gonzalez R
Ann Surg Oncol; 2007 Oct; 14(10):2854-60. PubMed ID: 17593331
[TBL] [Abstract][Full Text] [Related]
18. Impaired function of circulating dendritic cells in patients with pancreatic cancer.
Yanagimoto H; Takai S; Satoi S; Toyokawa H; Takahashi K; Terakawa N; Kwon AH; Kamiyama Y
Clin Immunol; 2005 Jan; 114(1):52-60. PubMed ID: 15596409
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
[TBL] [Abstract][Full Text] [Related]
20. A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patients.
Messina G; Lissoni P; Bartolacelli E; Tancini G; Villa S; Gardani GS; Brivio F
J Biol Regul Homeost Agents; 2003; 17(4):322-6. PubMed ID: 15065761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
